QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 why-processa-pharmaceuticals-stock-rose-almost-38-overnight

Processa Pharmaceuticals shares jumped 37.5% after hours following a strong regular session, despite facing significant losses ...

 hc-wainwright--co-maintains-buy-on-processa-pharmaceuticals-lowers-price-target-to-1

HC Wainwright & Co. analyst Raghuram Selvaraju maintains Processa Pharmaceuticals (NASDAQ:PCSA) with a Buy and lowers th...

 processa-pharma-q2-eps-025-misses-020-estimate

Processa Pharma (NASDAQ:PCSA) reported quarterly losses of $(0.25) per share which missed the analyst consensus estimate of $(0...

 processa-pharmaceuticals-signs-binding-term-sheet-granting-intact-therapeutics-an-exclusive-option-to-license-pcs12852-strengthens-balance-sheet-with-7m-capital-infusion

Signed binding term sheet granting Intact Therapeutics an exclusive option to license PCS12852Continue enrolling patients in Ph...

 hc-wainwright--co-maintains-buy-on-processa-pharmaceuticals-lowers-price-target-to-2

HC Wainwright & Co. analyst Raghuram Selvaraju maintains Processa Pharmaceuticals (NASDAQ:PCSA) with a Buy and lowers th...

 processa-pharmaceuticals-prices-7m-public-offering-of-28m-shares-and-warrants-at-025-each

Processa Pharmaceuticals, Inc. (NASDAQ:PCSA) (the "Company"), a clinical-stage pharmaceutical company developing Next G...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION